NEW YORK, NY, UNITED STATES, January 12, 2026 /EINPresswire.com/ — Micoy Therapeutics today announced that the NeuroLume™ Test has been granted Breakthrough ...

The FDA has expanded its approval of leucovorin calcium tablets to treat cerebral folate deficiency in patients with a folate receptor 1 gene variant, according to a press release from the agency.

FDA Breakthrough designation supports development of a point-of-care test for detecting folate receptor autoantibodies NEW YORK, NY, UNITED STATES, January 12, 2026 ...